A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties

Completed · Phase 4

Conditions studied: Relapsing-Remitting Multiple Sclerosis

In brief

The purpose of this study is to determine if medication designed to improve memory will help patients with Multiple Sclerosis (MS) who are experiencing memory problems using fMRI to track brain activity.

Key facts

Study ID

NCT00315367

Run by

Neurognostics

People needed

26

Starts

2004-09-01

Expected to finish

2007-10-01

Last updated by the study team

2007-10-16

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Between 18 and 65 years of age and experiencing some forgetfulness
• Diagnosed with MS, currently taking Rebif® and experiencing mild memory problems
• Participants will have stable medication dosages 1 month prior to testing
• With no past or present neurological disorders (e.g. head trauma, seizures, encephalitis, stroke) except MS
• With no known medical illnesses (e.g. diabetes, uncontrolled hypertension, arthritis)
• With no psychiatric illness
• With no current substance abuse
• Females should not be pregnant or nursing
• With no metallic devices in the body or claustrophobia

You may not qualify if…

• Previous history of CNS disturbance other than MS
• Severe motor or visual impairment that might interfere with the cognitive activation tasks
• Prescribed psychoactive medications
• Memory deficits caused by other significant neurological disease or psychiatric disorder
• Active malignancy within one year of study participation
• Known human immunodeficiency virus (HIV)
• Current diagnosis of unstable glaucoma; history of myocardial infarction
• Symptomatic Coronary Artery Disease within the last 12 months or evidence of ongoing ischemia or uncontrolled atrial or ventricular arrhythmias as shown by ECG; poorly controlled or labile hypertension
• History of epilepsy or other seizure disorder within the past 12 months
• Allergy or hypersensitivity to amphetamines or other sympathomimetic amines

Where it is running

• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.